2025 NURS 6630 Final Exam
Prep Test With 76 Correctly
Answered Questions And
Correct Answers// Nurs
6630 Psychopharmacology
Final Exam Prep 2025-2026
Nurs 6630 Final Exam
, lOMoAR cPSD| 21953575
NURS 6630 FINAL EXAM
QUESTION 1
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs
tomanage the top-down cortical control and the excessive drive from striatal hyperactivity?
A. Stimulants B. Antidepressants C. Antipsychotics D. SSRIs
QUESTION 2
The PMHNP is selecting a medication treatment option for a patient who is exhibiting
psychotic behaviors with poor impulse control and aggression. Of the available treatments,
which can help temper some of the adverse effects or symptoms that are normally caused
by D2 antagonism?
A. First-generation, conventional antipsychotics B. First-generation, atypical antipsychotics
C. Second-generation, conventional antipsychotics D. Second-generation, atypical
antipsychotics
QUESTION 3
The PMHNP is discussing dopamine D2 receptor occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a
standard dose of atypical antipsychotics?
A. The doses are based on achieving 100% D2 receptor occupancy. B. The doses are based
on achieving a minimum of 80% D2 receptor occupancy. C. The doses are based on
achieving 60% D2 receptor occupancy. D. None of the above.
pg. 1
, lOMoAR cPSD| 21953575
QUESTION 4
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects. B. It can exaggerate the
psychotic symptoms. C. Clozapine (Clozaril) should not be used as high-dose monotherapy.
D. There is no documentation that clozapine (Clozaril) is effective for patients who are
violent.
QUESTION 5
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the
PMHNP exhibits proper care for this patient?
A. Explaining to the patient that there are no risks of EPS B. Prescribing the patient 12
mg/dail
C. Titrating the dose by increasing it every 5–7 days D. Writing a prescription for a
higher dose of oral risperidone (Risperdal) to achieve high D2 receptor occupancy
QUESTION 6
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and
impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood
stabilizer willthe PMHNP select? A. Lithium (Lithane) B. Phenytoin (Dilantin) C. Valproate
(Depakote) D. Topiramate (Topamax)
pg. 2
, lOMoAR cPSD| 21953575
QUESTION 7
The parents of a 7-year-old patient with ADHD are concerned about the effects of
stimulants on their child. The parents prefer to start pharmacological treatment with a
non-stimulant. Which medication will the PMHNP will most likely prescribe?
A. Strattera B. Concerta C. Daytrana D.
AdderallQUESTION 8
8 The PMHNP understands that slow-dose extended release stimulants are most
appropriate forwhich patient with ADHD?
A. 8-year-old patient B. 24-year-old patient C. 55-year-old patient D. 82-year-old patient
QUESTION 9
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should
the PMHNP include when discussing the side effects with the patient?
A. The formulation can have delayed actions when taken with food. B. Sedation can be a
common side effect of the drug. C. The medication can affect your blood pressure. D.
This drug does not cause any dependency.
QUESTION 10
The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will
thePMHNP include in the teaching?
pg. 3
Prep Test With 76 Correctly
Answered Questions And
Correct Answers// Nurs
6630 Psychopharmacology
Final Exam Prep 2025-2026
Nurs 6630 Final Exam
, lOMoAR cPSD| 21953575
NURS 6630 FINAL EXAM
QUESTION 1
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs
tomanage the top-down cortical control and the excessive drive from striatal hyperactivity?
A. Stimulants B. Antidepressants C. Antipsychotics D. SSRIs
QUESTION 2
The PMHNP is selecting a medication treatment option for a patient who is exhibiting
psychotic behaviors with poor impulse control and aggression. Of the available treatments,
which can help temper some of the adverse effects or symptoms that are normally caused
by D2 antagonism?
A. First-generation, conventional antipsychotics B. First-generation, atypical antipsychotics
C. Second-generation, conventional antipsychotics D. Second-generation, atypical
antipsychotics
QUESTION 3
The PMHNP is discussing dopamine D2 receptor occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a
standard dose of atypical antipsychotics?
A. The doses are based on achieving 100% D2 receptor occupancy. B. The doses are based
on achieving a minimum of 80% D2 receptor occupancy. C. The doses are based on
achieving 60% D2 receptor occupancy. D. None of the above.
pg. 1
, lOMoAR cPSD| 21953575
QUESTION 4
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects. B. It can exaggerate the
psychotic symptoms. C. Clozapine (Clozaril) should not be used as high-dose monotherapy.
D. There is no documentation that clozapine (Clozaril) is effective for patients who are
violent.
QUESTION 5
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the
PMHNP exhibits proper care for this patient?
A. Explaining to the patient that there are no risks of EPS B. Prescribing the patient 12
mg/dail
C. Titrating the dose by increasing it every 5–7 days D. Writing a prescription for a
higher dose of oral risperidone (Risperdal) to achieve high D2 receptor occupancy
QUESTION 6
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and
impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood
stabilizer willthe PMHNP select? A. Lithium (Lithane) B. Phenytoin (Dilantin) C. Valproate
(Depakote) D. Topiramate (Topamax)
pg. 2
, lOMoAR cPSD| 21953575
QUESTION 7
The parents of a 7-year-old patient with ADHD are concerned about the effects of
stimulants on their child. The parents prefer to start pharmacological treatment with a
non-stimulant. Which medication will the PMHNP will most likely prescribe?
A. Strattera B. Concerta C. Daytrana D.
AdderallQUESTION 8
8 The PMHNP understands that slow-dose extended release stimulants are most
appropriate forwhich patient with ADHD?
A. 8-year-old patient B. 24-year-old patient C. 55-year-old patient D. 82-year-old patient
QUESTION 9
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should
the PMHNP include when discussing the side effects with the patient?
A. The formulation can have delayed actions when taken with food. B. Sedation can be a
common side effect of the drug. C. The medication can affect your blood pressure. D.
This drug does not cause any dependency.
QUESTION 10
The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will
thePMHNP include in the teaching?
pg. 3
